<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title>Duane Morris LLP Intellectual Property Alerts and Updates</title>
    <copyright>Copyright (c)2026 Duane Morris LLP</copyright>   
    <link>//www.duanemorris.com</link>
    <description>RSS Feed from law firm Duane Morris LLP</description>
    <language>en-us</language>
    <lastBuildDate>2026-07-17T02:11:57-04:00</lastBuildDate>
    <item>
      <title>&quot;2&quot; Does Not Equal &quot;1&quot; – A Reminder That Provisional Patent Applications Must Sufficiently Describe the Underlying Subject Matter for a Priority Claim</title>
      <link>/alerts/2_does_not_equal_1_reminder_that_provisional_patent_applications_must_sufficiently_0726.html</link>
      <guid>/alerts/2_does_not_equal_1_reminder_that_provisional_patent_applications_must_sufficiently_0726.html</guid>
      <pubDate>2026-07-07T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>U.S. Supreme Court Reverses Federal Circuit, Holding No Induced Infringement Plausibly Pled Based on Skinny Label and Related Statements</title>
      <link>/alerts/us_supreme_court_reverses_federal_circuit_court_holding_no_skinny_label_infringement_0626.html</link>
      <guid>/alerts/us_supreme_court_reverses_federal_circuit_court_holding_no_skinny_label_infringement_0626.html</guid>
      <pubDate>2026-06-15T09:27:36-04:00</pubDate>
    </item>
    <item>
      <title>Federal Regulatory Response to New World Screwworm and Implications for the Agricultural and Animal Health Industries</title>
      <link>/alerts/federal_regulatory_response_new_world_screwworm_implications_agricultural_animal_health_0526.html</link>
      <guid>/alerts/federal_regulatory_response_new_world_screwworm_implications_agricultural_animal_health_0526.html</guid>
      <pubDate>2026-05-28T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Montana&apos;s Draft Rules for Experimental Treatment Centers Under SB 535 – Key Highlights for Stakeholders</title>
      <link>/alerts/montanas_draft_rules_experimental_treatment_centers_under_sb535_key_highlights_0526.html</link>
      <guid>/alerts/montanas_draft_rules_experimental_treatment_centers_under_sb535_key_highlights_0526.html</guid>
      <pubDate>2026-05-21T09:08:24-04:00</pubDate>
    </item>
    <item>
      <title>Ambiguity of Measurement Conditions for Relevant Chemical Property Leads to Federal Circuit Affirming Noninfringement of Epoprostenol Patents</title>
      <link>/alerts/ambiguity_measurement_conditions_relevant_chemical_property_leads_federal_circuit_0526.html</link>
      <guid>/alerts/ambiguity_measurement_conditions_relevant_chemical_property_leads_federal_circuit_0526.html</guid>
      <pubDate>2026-05-18T08:50:37-04:00</pubDate>
    </item>
    <item>
      <title>A Patent&apos;s Demise – Inventor Gone Without a Trace </title>
      <link>/alerts/patents_demise_inventor_gone_without_a_trace_0426.html</link>
      <guid>/alerts/patents_demise_inventor_gone_without_a_trace_0426.html</guid>
      <pubDate>2026-04-09T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Explicit Apprehension of Prior Art Reference Disclosure Does Not Support Finding of Inequitable Conduct on Summary Judgment</title>
      <link>/alerts/explicit_apprehension_prior_art_reference_disclosure_does_not_support_finding_inequitable_0326.html</link>
      <guid>/alerts/explicit_apprehension_prior_art_reference_disclosure_does_not_support_finding_inequitable_0326.html</guid>
      <pubDate>2026-03-04T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>U.S. Supreme Court Grants Certiorari in Hikma&amp;nbsp;v. Amarin, Placing &quot;Skinny Label&quot; Inducement in Focus</title>
      <link>/alerts/us_supreme_court_grants_certiorari_hikma_amarin_placing_skinny_label_inducement_focus_0126.html</link>
      <guid>/alerts/us_supreme_court_grants_certiorari_hikma_amarin_placing_skinny_label_inducement_focus_0126.html</guid>
      <pubDate>2026-01-20T14:14:36-05:00</pubDate>
    </item>
    <item>
      <title>FDA Launches the TEMPO Pilot for Digital Health Devices to Improve Patient Access to Technologies</title>
      <link>/alerts/fda_launches_tempo_pilot_digital_health_devices_improve_patient_access_technologies_0126.html</link>
      <guid>/alerts/fda_launches_tempo_pilot_digital_health_devices_improve_patient_access_technologies_0126.html</guid>
      <pubDate>2026-01-07T13:45:37-05:00</pubDate>
    </item>
    <item>
      <title>FDA Proposes Rule to Reclassify Oncology Therapeutic Nucleic Acid-Based Test Systems as Class II Devices</title>
      <link>/alerts/fda_proposes_rule_reclassify_oncology_therapeutic_nucleic_acid_based_test_systems_class_1225.html</link>
      <guid>/alerts/fda_proposes_rule_reclassify_oncology_therapeutic_nucleic_acid_based_test_systems_class_1225.html</guid>
      <pubDate>2025-12-17T09:14:53-05:00</pubDate>
    </item>
    <item>
      <title>USPTO Signals Strong Support for Patent Eligibility in Cutting-Edge Technologies</title>
      <link>/alerts/uspto_signals_strong_support_patent_eligibility_cutting_edge_technologies_1225.html</link>
      <guid>/alerts/uspto_signals_strong_support_patent_eligibility_cutting_edge_technologies_1225.html</guid>
      <pubDate>2025-12-11T09:03:24-05:00</pubDate>
    </item>
    <item>
      <title>Copyrightability of AI-Generated Works – Petition for Certiorari Tees Up Supreme Court Review of Test Case on &quot;Human Authorship&quot;</title>
      <link>/alerts/copyrightability_ai_generated_works_petition_certiorari_tees_up_supreme_court_review_1125.html</link>
      <guid>/alerts/copyrightability_ai_generated_works_petition_certiorari_tees_up_supreme_court_review_1125.html</guid>
      <pubDate>2025-11-18T10:23:11-05:00</pubDate>
    </item>
    <item>
      <title>California Leads the Way in Consumer-Facing AI Regulation with Automated Decisionmaking Technology Rules</title>
      <link>/alerts/california_leads_way_consumer_facing_ai_regulation_automated_decisonmaking_technology_1025.html</link>
      <guid>/alerts/california_leads_way_consumer_facing_ai_regulation_automated_decisonmaking_technology_1025.html</guid>
      <pubDate>2025-10-07T09:20:40-04:00</pubDate>
    </item>
    <item>
      <title>Joint Commission and Coalition for Health AI Issue Guidance on Provider Use of AI</title>
      <link>/alerts/joint_commission_coalition_health_ai_issue_guidance_provider_use_ai_0925.html</link>
      <guid>/alerts/joint_commission_coalition_health_ai_issue_guidance_provider_use_ai_0925.html</guid>
      <pubDate>2025-09-29T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Commerce Department Singles Out Harvard for Bayh-Dole March-In Rights Enforcement</title>
      <link>/alerts/commerce_department_singles_out_harvard_bayh_dole_march_in_rights_0825.html</link>
      <guid>/alerts/commerce_department_singles_out_harvard_bayh_dole_march_in_rights_0825.html</guid>
      <pubDate>2025-08-19T10:17:47-04:00</pubDate>
    </item>
    <item>
      <title>Prosecution History Can Inform an Atypical Meaning of a Patent Claim Term</title>
      <link>/alerts/prosecution_history_can_inform_atypical_meaning_patent_claim_term_0725.html</link>
      <guid>/alerts/prosecution_history_can_inform_atypical_meaning_patent_claim_term_0725.html</guid>
      <pubDate>2025-07-18T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Northern District of California Decides AI Training Is Fair Use, but Pirating Books May Still Be Infringing</title>
      <link>/alerts/northern_district_california_decides_ai_training_is_fair_use_pirating_books_may_still_be_0725.html</link>
      <guid>/alerts/northern_district_california_decides_ai_training_is_fair_use_pirating_books_may_still_be_0725.html</guid>
      <pubDate>2025-07-02T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Again Declines to Weigh In on Discovery Rule&apos;s Application to Copyright Infringement Claims </title>
      <link>/alerts/supreme_court_again_declines_weigh_in_discovery_rules_application_copyrights_infringement_0625.html</link>
      <guid>/alerts/supreme_court_again_declines_weigh_in_discovery_rules_application_copyrights_infringement_0625.html</guid>
      <pubDate>2025-06-24T09:53:34-04:00</pubDate>
    </item>
    <item>
      <title>Your Definition, Your Rules, Your Consequences - Pitfalls of Lexicography in Patent Applications</title>
      <link>/alerts/your_definition_your_rules_your_consequences_pitfalls_lexicography_patent_applications_0625.html</link>
      <guid>/alerts/your_definition_your_rules_your_consequences_pitfalls_lexicography_patent_applications_0625.html</guid>
      <pubDate>2025-06-13T09:31:57-04:00</pubDate>
    </item>
    <item>
      <title>Montana Set to Become a &quot;Wild West&quot; Hub for Experimental Medical Treatments and Therapies </title>
      <link>/alerts/montana_set_become_wild_west_hub_experimental_medical_treatments_therapies_0525.html</link>
      <guid>/alerts/montana_set_become_wild_west_hub_experimental_medical_treatments_therapies_0525.html</guid>
      <pubDate>2025-05-22T10:16:26-04:00</pubDate>
    </item>
    <item>
      <title>How West Virginia&apos;s HB 2354 Will Impact the Food Industry</title>
      <link>/alerts/how_west_virginias_hb2354_will_impact_food_industry_0425.html</link>
      <guid>/alerts/how_west_virginias_hb2354_will_impact_food_industry_0425.html</guid>
      <pubDate>2025-04-21T10:15:01-04:00</pubDate>
    </item>
    <item>
      <title>U.S. Surgeon General Advisory on Alcohol and Cancer Risks Prompts Legal and Regulatory Considerations for Industry</title>
      <link>/alerts/us_surgeon_general_advisory_alcohol_prompts_legal_considerations_0225.html</link>
      <guid>/alerts/us_surgeon_general_advisory_alcohol_prompts_legal_considerations_0225.html</guid>
      <pubDate>2025-02-19T13:09:29-05:00</pubDate>
    </item>
    <item>
      <title>FDA AI Guidance - A New Era for Biotech, Diagnostics and Regulatory Compliance</title>
      <link>/alerts/fda_ai_guidance_new_era_biotech_diagnostics_regulatory_compliance_0225.html</link>
      <guid>/alerts/fda_ai_guidance_new_era_biotech_diagnostics_regulatory_compliance_0225.html</guid>
      <pubDate>2025-02-12T08:40:40-05:00</pubDate>
    </item>
    <item>
      <title>Earlier-Filed, Later-Published Patent Applications Available as Prior Art in Inter Partes Review</title>
      <link>/alerts/earlier_filed_later_published_patent_applications_available_prior_art_inter_partes_review_0225.html</link>
      <guid>/alerts/earlier_filed_later_published_patent_applications_available_prior_art_inter_partes_review_0225.html</guid>
      <pubDate>2025-02-03T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>FDA Revokes Red Dye No. 3 Authorization for Food, Drinks and Drugs - What Manufacturers Need to Know</title>
      <link>/alerts/fda_revokes_red_dye_no3_authorization_food_drinks_drugs_what_manufacturers_need_know_0125.html</link>
      <guid>/alerts/fda_revokes_red_dye_no3_authorization_food_drinks_drugs_what_manufacturers_need_know_0125.html</guid>
      <pubDate>2025-01-30T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Affirms Delisting Patents Claiming Device Components of Drug Product Without Active Ingredient</title>
      <link>/alerts/federal_circuit_affirms_delisting_patents_claiming_device_components_drug_product_without_0125.html</link>
      <guid>/alerts/federal_circuit_affirms_delisting_patents_claiming_device_components_drug_product_without_0125.html</guid>
      <pubDate>2025-01-23T09:25:54-05:00</pubDate>
    </item>
    <item>
      <title>Second Circuit Declines to Revisit Discovery Rule in Copyright Infringement Claims</title>
      <link>/alerts/second_circuit_declines_revisit_discovery_rule_copyright_infringement_claims_1124.html</link>
      <guid>/alerts/second_circuit_declines_revisit_discovery_rule_copyright_infringement_claims_1124.html</guid>
      <pubDate>2024-11-13T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>California Requires Digital Storefronts to Provide Terms of Licenses on Digital Goods </title>
      <link>/alerts/california_requires_digital_storefronts_provide_terms_licenses_digital_goods_1024.html</link>
      <guid>/alerts/california_requires_digital_storefronts_provide_terms_licenses_digital_goods_1024.html</guid>
      <pubDate>2024-10-30T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Second Circuit Says &quot;Sophisticated&quot; Plaintiffs Are Not Precluded from Relying on the Discovery Rule to Bring Copyright Infringement Claims</title>
      <link>/alerts/second_circuit_says_sophisticated_plaintiffs_are_not_precluded_relying_discovery_rule_0824.html</link>
      <guid>/alerts/second_circuit_says_sophisticated_plaintiffs_are_not_precluded_relying_discovery_rule_0824.html</guid>
      <pubDate>2024-08-22T12:08:49-04:00</pubDate>
    </item>
    <item>
      <title>Patent Primogeniture: First-Filed, First-Issued and Later-Expiring Patent in a Family Immune from a Finding of Obviousness-Type Double Patenting</title>
      <link>/alerts/patent_primogeniture_first_filed_first_issued_later_expiring_patent_family_immune_finding_0824.html</link>
      <guid>/alerts/patent_primogeniture_first_filed_first_issued_later_expiring_patent_family_immune_finding_0824.html</guid>
      <pubDate>2024-08-19T09:45:06-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Revives Induced Infringement Suit Against Generic Pharma When Its Skinny Label Is Skinny Enough </title>
      <link>/alerts/federal_circuit_revives_induced_infringement_suit_against_generic_pharma_when_skinny_label_0724.html</link>
      <guid>/alerts/federal_circuit_revives_induced_infringement_suit_against_generic_pharma_when_skinny_label_0724.html</guid>
      <pubDate>2024-07-15T13:42:27-04:00</pubDate>
    </item>
    <item>
      <title>Pitfalls in Current Terminal Disclaimer Practice and Additional Problems for Patentees and Stakeholders in Proposed Changes</title>
      <link>/alerts/pitfalls_current_terminal_disclaimer_practice_additional_problems_patentees_stakeholders_0624.html</link>
      <guid>/alerts/pitfalls_current_terminal_disclaimer_practice_additional_problems_patentees_stakeholders_0624.html</guid>
      <pubDate>2024-06-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Leaves Discovery Rule Intact for Copyright Infringement Claims</title>
      <link>/alerts/supreme_court_leaves_discovery_rule_intact_copyright_infringement_claims_0524.html</link>
      <guid>/alerts/supreme_court_leaves_discovery_rule_intact_copyright_infringement_claims_0524.html</guid>
      <pubDate>2024-05-23T15:16:21-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Opens a Door for Copyright Infringement Damages – But Will It Be Closed in the Future?</title>
      <link>/alerts/supreme_court_opens_door_copyright_infringement_damages_but_will_it_be_closed_in_future_0524.html</link>
      <guid>/alerts/supreme_court_opens_door_copyright_infringement_damages_but_will_it_be_closed_in_future_0524.html</guid>
      <pubDate>2024-05-16T14:27:08-04:00</pubDate>
    </item>
    <item>
      <title>USPTO Proposes Significant Fee Increases Impacting Patent Prosecution Practices</title>
      <link>/alerts/uspto_proposes_significant_fee_increases_impacting_patent_prosecution_practices_0424.html</link>
      <guid>/alerts/uspto_proposes_significant_fee_increases_impacting_patent_prosecution_practices_0424.html</guid>
      <pubDate>2024-04-24T08:45:19-04:00</pubDate>
    </item>
    <item>
      <title>FDA Adopts ISO Standard for Device Makers in New Rule</title>
      <link>/alerts/fda_adopts_iso_standard_device_makers_new_rule_0324.html</link>
      <guid>/alerts/fda_adopts_iso_standard_device_makers_new_rule_0324.html</guid>
      <pubDate>2024-03-18T11:20:24-04:00</pubDate>
    </item>
    <item>
      <title>No Inequitable Conduct in Certifying Unintentional Abandonment of Patent Application Despite Counsel&apos;s Knowledge of Abandonment </title>
      <link>/alerts/no_inequitable_conduct_certifying_unintentional_abandonment_patent_application_despite_0324.html</link>
      <guid>/alerts/no_inequitable_conduct_certifying_unintentional_abandonment_patent_application_despite_0324.html</guid>
      <pubDate>2024-03-11T12:15:08-04:00</pubDate>
    </item>
    <item>
      <title>FTC Supports Marching In on Patent Rights as a Mechanism to Control Drug Prices</title>
      <link>/alerts/ftc_supports_marching_in_patent_rights_mechanism_control_drug_prices_0224.html</link>
      <guid>/alerts/ftc_supports_marching_in_patent_rights_mechanism_control_drug_prices_0224.html</guid>
      <pubDate>2024-02-15T14:18:14-05:00</pubDate>
    </item>
    <item>
      <title>FCC Order Requires One-to-One Consent and Codifies Do-Not-Call Rule for Texting</title>
      <link>/alerts/fcc_order_requires_one_to_one_consent_codifies_do_not_call_rule_texting_0124.html</link>
      <guid>/alerts/fcc_order_requires_one_to_one_consent_codifies_do_not_call_rule_texting_0124.html</guid>
      <pubDate>2024-01-10T09:16:14-05:00</pubDate>
    </item>
    <item>
      <title>White House Announces Framework for Use of March-In Rights Under the Bayh-Dole Act to Lower Drug Prices</title>
      <link>/alerts/white_house_announces_framework_use_march_in_rights_under_bayh_dole_act_lower_drug_prices_1223.html</link>
      <guid>/alerts/white_house_announces_framework_use_march_in_rights_under_bayh_dole_act_lower_drug_prices_1223.html</guid>
      <pubDate>2023-12-11T09:35:21-05:00</pubDate>
    </item>
    <item>
      <title>White House Artificial Intelligence Executive Order Impacts Myriad Sectors of the Law</title>
      <link>/alerts/white_house_artificial_intelligence_executive_order_impacts_myriad_sectors_law_1123.html</link>
      <guid>/alerts/white_house_artificial_intelligence_executive_order_impacts_myriad_sectors_law_1123.html</guid>
      <pubDate>2023-11-06T12:28:12-05:00</pubDate>
    </item>
    <item>
      <title>FTC Amends Safeguards Rule to Add a Breach Notification Requirement</title>
      <link>/alerts/ftc_amends_safeguards_rule_add_breach_notfifcation_requirement_1023.html</link>
      <guid>/alerts/ftc_amends_safeguards_rule_add_breach_notfifcation_requirement_1023.html</guid>
      <pubDate>2023-10-31T09:05:09-04:00</pubDate>
    </item>
    <item>
      <title>Patent Term Adjustment and Patent Term Extension Analyzed Differently in Consideration of Obviousness-Type Double Patenting</title>
      <link>/alerts/patent_term_adjustment_patent_term_extension_analyzed_differently_consideration_0923.html</link>
      <guid>/alerts/patent_term_adjustment_patent_term_extension_analyzed_differently_consideration_0923.html</guid>
      <pubDate>2023-09-11T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>New Senate Bill Proposes Regulating Name, Image and Likeness Rights for College Athletes </title>
      <link>/alerts/new_senate_bill_proposes_regulating_name_image_likeness_rights_college_athletes_0823.html</link>
      <guid>/alerts/new_senate_bill_proposes_regulating_name_image_likeness_rights_college_athletes_0823.html</guid>
      <pubDate>2023-08-10T10:07:15-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Affirms Federal Circuit Ruling Regarding Satisfaction of Enablement Requirement</title>
      <link>/alerts/supreme_court_affirms_federal_circuit_ruling_regarding_satisfaction_enablement_requirement_0523.html</link>
      <guid>/alerts/supreme_court_affirms_federal_circuit_ruling_regarding_satisfaction_enablement_requirement_0523.html</guid>
      <pubDate>2023-05-19T12:13:49-04:00</pubDate>
    </item>
    <item>
      <title>Finding Needles in a Haystack and Driving Down One-Way Streets: Recent Developments in the Application of Estoppel in Patent Proceedings</title>
      <link>/alerts/finding_needles_haystack_driving_down_one_way_streets_recent_developments_application_0423.html</link>
      <guid>/alerts/finding_needles_haystack_driving_down_one_way_streets_recent_developments_application_0423.html</guid>
      <pubDate>2023-04-13T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Customer-Suit Exception Extends to Joinder of Customers and Manufacturers in the Same Suit</title>
      <link>/alerts/customer_suit_exception_extends_joinder_customers_manufacturers_same_suit_0223.html</link>
      <guid>/alerts/customer_suit_exception_extends_joinder_customers_manufacturers_same_suit_0223.html</guid>
      <pubDate>2023-02-10T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Broad Patent Prosecution Bars Risk Effectively Decoupling Complementary Patent Litigation and Prosecution Practices</title>
      <link>/alerts/broad_patent_prosecution_bars_risk_effectively_decoupling_complementary_patent_litigation_0822.html</link>
      <guid>/alerts/broad_patent_prosecution_bars_risk_effectively_decoupling_complementary_patent_litigation_0822.html</guid>
      <pubDate>2022-08-22T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Coordinating IP and Regulatory Filings Can Minimize the Risk of Inequitable Conduct Before the PTO</title>
      <link>/alerts/coordinating_ip_regulatory_filings_can_minimize_risk_inequitable_conduct_before_pto_0822.html</link>
      <guid>/alerts/coordinating_ip_regulatory_filings_can_minimize_risk_inequitable_conduct_before_pto_0822.html</guid>
      <pubDate>2022-08-08T09:17:53-04:00</pubDate>
    </item>
    <item>
      <title>The Other Side of the Coin: Diligent Patent Prosecution Does Not Lead to Unreasonable Delay and Application of Prosecution Laches</title>
      <link>/alerts/other_side_coin_diligent_patent_prosecution_does_not_lead_unreasonable_delay_application_0722.html</link>
      <guid>/alerts/other_side_coin_diligent_patent_prosecution_does_not_lead_unreasonable_delay_application_0722.html</guid>
      <pubDate>2022-07-22T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Silence Is Not Necessarily Golden for Negative Patent Claim Limitations</title>
      <link>/alerts/silence_is_not_necessarily_golden_negative_patent_claim_limitations_0722.html</link>
      <guid>/alerts/silence_is_not_necessarily_golden_negative_patent_claim_limitations_0722.html</guid>
      <pubDate>2022-07-07T14:17:52-04:00</pubDate>
    </item>
    <item>
      <title>Russian Sanctions Could Impact IP Holdings in Russia and Eurasia </title>
      <link>/alerts/russian_sanctions_could_impact_ip_holdings_russia_eurasia_0322.html</link>
      <guid>/alerts/russian_sanctions_could_impact_ip_holdings_russia_eurasia_0322.html</guid>
      <pubDate>2022-03-25T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title> The INFORM Consumers Act&apos;s Effects on the Consumer Products Industry</title>
      <link>/alerts/inform_consumers_acts_effects_consumer_products_industry_0322.html</link>
      <guid>/alerts/inform_consumers_acts_effects_consumer_products_industry_0322.html</guid>
      <pubDate>2022-03-22T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>District Court of Delaware Rules for Generic Pharma&apos;s Use of Skinny Label, but Permits Induced Infringement Suit to Proceed Against Insurer</title>
      <link>/alerts/district_court_delaware_rules_generic_pharmas_use_skinny_label_permits_induced_0222.html</link>
      <guid>/alerts/district_court_delaware_rules_generic_pharmas_use_skinny_label_permits_induced_0222.html</guid>
      <pubDate>2022-02-10T14:31:04-05:00</pubDate>
    </item>
    <item>
      <title>U.S. Patent and Trademark Office Implements Trademark Modernization Act, Paving the Way to Clear the Federal Register </title>
      <link>/alerts/us_patent_trademark_office_implements_trademark_modernization_act_paving_way_clear_1121.html</link>
      <guid>/alerts/us_patent_trademark_office_implements_trademark_modernization_act_paving_way_clear_1121.html</guid>
      <pubDate>2021-11-23T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit&apos;s Rehearing Decision Confirms Induced Infringement Even When Skinny Label Was Used</title>
      <link>/alerts/federal_circuits_rehearing_decision_confirms_induced_infringement_even_when_skinny_label_0821.html</link>
      <guid>/alerts/federal_circuits_rehearing_decision_confirms_induced_infringement_even_when_skinny_label_0821.html</guid>
      <pubDate>2021-08-30T15:21:27-04:00</pubDate>
    </item>
    <item>
      <title>Paying for Your Delay: Application of Prosecution Laches Can Render Issued Patents Unenforceable</title>
      <link>/alerts/paying_your_delay_application_prosecution_laches_can_render_issued_patents_unenforceable_0821.html</link>
      <guid>/alerts/paying_your_delay_application_prosecution_laches_can_render_issued_patents_unenforceable_0821.html</guid>
      <pubDate>2021-08-17T09:06:33-04:00</pubDate>
    </item>
    <item>
      <title>Sharing the Blame: Parent Company Can Still Be on the Hook for Subsidiary&apos;s Alleged Infringement</title>
      <link>/alerts/sharing_blame_parent_company_can_still_be_hook_subsidiarys_alleged_infringement_0521.html</link>
      <guid>/alerts/sharing_blame_parent_company_can_still_be_hook_subsidiarys_alleged_infringement_0521.html</guid>
      <pubDate>2021-05-25T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Considerations and Implications of the Proposed Temporary Waiver of COVID-19 Vaccine-Related Intellectual Property Rights </title>
      <link>/alerts/considerations_implications_proposed_temporary_waiver_covid19_vaccine_related_intellectual_0521.html</link>
      <guid>/alerts/considerations_implications_proposed_temporary_waiver_covid19_vaccine_related_intellectual_0521.html</guid>
      <pubDate>2021-05-06T13:41:45-04:00</pubDate>
    </item>
    <item>
      <title>Texas Court Will Not Delay In-Person Trial to Permit Vaccination of Participants </title>
      <link>/alerts/texas_court_will_not_delay_in_person_trial_permit_vaccination_participants_0321.html</link>
      <guid>/alerts/texas_court_will_not_delay_in_person_trial_permit_vaccination_participants_0321.html</guid>
      <pubDate>2021-03-22T15:27:42-04:00</pubDate>
    </item>
    <item>
      <title>Who Watches the Watchmen? Supreme Court to Decide Fate of Administrative Patent Judge Appointments</title>
      <link>/alerts/who_watches_watchmen_supreme_court_decide_fate_administrative_patent_judge_appointments_0321.html</link>
      <guid>/alerts/who_watches_watchmen_supreme_court_decide_fate_administrative_patent_judge_appointments_0321.html</guid>
      <pubDate>2021-03-08T15:04:43-05:00</pubDate>
    </item>
    <item>
      <title>Forum Selection Clause Held Inapplicable for Precluding Inter Partes Review Before the Patent and Trial Appeal Board</title>
      <link>/alerts/forum_selection_clause_held_inapplicable_precluding_inter_partes_review_patent_trial_0221.html</link>
      <guid>/alerts/forum_selection_clause_held_inapplicable_precluding_inter_partes_review_patent_trial_0221.html</guid>
      <pubDate>2021-02-08T12:23:30-05:00</pubDate>
    </item>
    <item>
      <title>December 2020 COVID-19 Relief Bill Finally Closes the Streaming Loophole  </title>
      <link>/alerts/december_2020_covid19_relief_bill_finally_closes_streaming_loophole_0221.html</link>
      <guid>/alerts/december_2020_covid19_relief_bill_finally_closes_streaming_loophole_0221.html</guid>
      <pubDate>2021-02-02T14:20:35-05:00</pubDate>
    </item>
    <item>
      <title>U.S. Trademark Office Offers New Tools Against Registrations Granted Without Use in Commerce</title>
      <link>/alerts/us_trademark_office_offers_new_tools_against_registrations_granted_without_use_commerce_0121.html</link>
      <guid>/alerts/us_trademark_office_offers_new_tools_against_registrations_granted_without_use_commerce_0121.html</guid>
      <pubDate>2021-01-25T15:22:39-05:00</pubDate>
    </item>
    <item>
      <title>New Copyright Claims Board May Have Limited Appeal</title>
      <link>/alerts/new_copyright_claims_board_may_have_limited_appeal_0121.html</link>
      <guid>/alerts/new_copyright_claims_board_may_have_limited_appeal_0121.html</guid>
      <pubDate>2021-01-19T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Trademark Modernization Act Provides Trademark Owners Easier Access to Injunctions Against Infringers </title>
      <link>/alerts/trademark_modernization_act_provides_trademark_owners_easier_access_injunctions_0121.html</link>
      <guid>/alerts/trademark_modernization_act_provides_trademark_owners_easier_access_injunctions_0121.html</guid>
      <pubDate>2021-01-11T12:25:00-05:00</pubDate>
    </item>
    <item>
      <title>Patent-Eligible Subject Matter in Biotech Should Recite More Than a &quot;Telescope&quot;</title>
      <link>/alerts/patent_eligible_subject_matter_biotech_should_recite_more_than_telescope_1220.html</link>
      <guid>/alerts/patent_eligible_subject_matter_biotech_should_recite_more_than_telescope_1220.html</guid>
      <pubDate>2020-12-08T14:34:45-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Holds That, for Venue Purposes, Patent Infringement Occurs Only in Districts Where Actions Related to ANDA Submissions Occur</title>
      <link>/alerts/federal_circuit_holds_venue_purposes_patent_infringement_occurs_only_districts_where_1120.html</link>
      <guid>/alerts/federal_circuit_holds_venue_purposes_patent_infringement_occurs_only_districts_where_1120.html</guid>
      <pubDate>2020-11-18T14:02:09-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Finds Induced Infringement of Drug Patent, Even When Skinny Label Was Used</title>
      <link>/alerts/federal_circuit_finds_induced_infringement_drug_patent_even_when_skinny_label_was_used_1020.html</link>
      <guid>/alerts/federal_circuit_finds_induced_infringement_drug_patent_even_when_skinny_label_was_used_1020.html</guid>
      <pubDate>2020-10-30T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Playing Your Cards Right: Arguments Against Obviousness Can Be Detrimental for Satisfying the Written Description Requirement</title>
      <link>/alerts/playing_your_cards_right_arguments_against_obviousness_can_be_detrimental_satisfying_0720.html</link>
      <guid>/alerts/playing_your_cards_right_arguments_against_obviousness_can_be_detrimental_satisfying_0720.html</guid>
      <pubDate>2020-07-02T09:12:00-04:00</pubDate>
    </item>
    <item>
      <title>The Capricious and Ever-Changing Nature of IP Practice Under COVID-19: Deadline Extensions, Sometimes with a Catch, and Ungracious Grace Periods</title>
      <link>/alerts/ip_practice_under_covid19_deadline_extensions_catch_ungracious_grace_periods_0420.html</link>
      <guid>/alerts/ip_practice_under_covid19_deadline_extensions_catch_ungracious_grace_periods_0420.html</guid>
      <pubDate>2020-05-04T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Protecting Against Government Intrusion for COVID-19 Therapies</title>
      <link>/alerts/protecting_against_government_intrusion_covid19_therapies_0420.html</link>
      <guid>/alerts/protecting_against_government_intrusion_covid19_therapies_0420.html</guid>
      <pubDate>2020-04-07T12:51:50-04:00</pubDate>
    </item>
    <item>
      <title>Numerical Ranges: More Than Just Endpoints in Patent Process</title>
      <link>/alerts/numerical_ranges_more_than_just_endpoints_patent_process_0220.html</link>
      <guid>/alerts/numerical_ranges_more_than_just_endpoints_patent_process_0220.html</guid>
      <pubDate>2020-02-14T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Is Your Trademark Case Exceptional? Seventh Circuit Extends Octane Standard to the Lanham Act</title>
      <link>/alerts/trademark_exceptional_seventh_circuit_extends_octane_standard_lanham_act_1119.html</link>
      <guid>/alerts/trademark_exceptional_seventh_circuit_extends_octane_standard_lanham_act_1119.html</guid>
      <pubDate>2019-11-11T14:51:58-05:00</pubDate>
    </item>
    <item>
      <title>Are Trademarks FUCT? SCOTUS Strikes Down Ban on Registering &quot;Immoral&quot; and &quot;Scandalous&quot; Trademarks</title>
      <link>/alerts/are_trademarks_fuct_scotus_strikes_down_ban_registering_immoral_trademarks_0619.html</link>
      <guid>/alerts/are_trademarks_fuct_scotus_strikes_down_ban_registering_immoral_trademarks_0619.html</guid>
      <pubDate>2019-06-28T09:33:49-04:00</pubDate>
    </item>
    <item>
      <title>With Hemp Legalized by 2018 Farm Bill, Patent and Trademark Office Issues New Guidelines</title>
      <link>/alerts/hemp_legalized_2018_farm_bill_patent_trademark_office_issues_new_guidelines_0519.html</link>
      <guid>/alerts/hemp_legalized_2018_farm_bill_patent_trademark_office_issues_new_guidelines_0519.html</guid>
      <pubDate>2019-05-06T14:41:22-04:00</pubDate>
    </item>
    <item>
      <title>UCANN&apos;s Liquid Cannabis Patent Survives Section 101 Challenge by Pure Hemp; Judge Questions Novelty, Usefulness and Nonobviousness</title>
      <link>/alerts/ucanns_liquid_cannabis_patent_survives_section101_challenge_pure_hemp_0419.html</link>
      <guid>/alerts/ucanns_liquid_cannabis_patent_survives_section101_challenge_pure_hemp_0419.html</guid>
      <pubDate>2019-04-22T15:20:27-04:00</pubDate>
    </item>
    <item>
      <title>What Your Competitors Don’t Know Can Hurt You - The Supreme Court Rules that Secret Sales Can Trigger the On-Sale Bar Under the AIA </title>
      <link>/alerts/supreme_court_rules_secret_sales_trigger_on_sale_bar_under_aia_0119.html</link>
      <guid>/alerts/supreme_court_rules_secret_sales_trigger_on_sale_bar_under_aia_0119.html</guid>
      <pubDate>2019-01-24T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>FDA Estimates for Formal Meetings Regarding Development of Biosimilars Show Continued Growth of Biosimilars in the United States</title>
      <link>/alerts/fda_estimates_formal_meetings_regarding_development_biosimilar_continued_growth_1018.html</link>
      <guid>/alerts/fda_estimates_formal_meetings_regarding_development_biosimilar_continued_growth_1018.html</guid>
      <pubDate>2018-10-02T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FTC Recommends Ways to Increase Competition and Stimulate Growth in Biosimilars and Interchangeable Market</title>
      <link>/alerts/ftc_recommends_ways_increase_competition_stimulate_growth_biosimilars_0818.html</link>
      <guid>/alerts/ftc_recommends_ways_increase_competition_stimulate_growth_biosimilars_0818.html</guid>
      <pubDate>2018-08-09T15:14:11-04:00</pubDate>
    </item>
    <item>
      <title>FDA Proposes to Amend Product Jurisdiction Regulations Without Any Significant Substantive Changes</title>
      <link>/alerts/fda_proposes_amend_product_jurisdiction_regulations_without_significant_changes_0618.html</link>
      <guid>/alerts/fda_proposes_amend_product_jurisdiction_regulations_without_significant_changes_0618.html</guid>
      <pubDate>2018-06-12T10:51:47-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Reaffirms Rule That a Priority Claim Must Include the Entire Chain of Priority</title>
      <link>/alerts/federal_circuit_reaffirms_rule_priority_claim_must_include_entire_chain_priority_0418.html</link>
      <guid>/alerts/federal_circuit_reaffirms_rule_priority_claim_must_include_entire_chain_priority_0418.html</guid>
      <pubDate>2018-04-26T10:48:31-04:00</pubDate>
    </item>
    <item>
      <title>Reforming Myanmar&apos;s Intellectual Property Laws</title>
      <link>/alerts/reforming_myanmars_intellectual_property_laws_0917.html</link>
      <guid>/alerts/reforming_myanmars_intellectual_property_laws_0917.html</guid>
      <pubDate>2017-09-29T14:46:07-04:00</pubDate>
    </item>
    <item>
      <title>FDA Issues Draft Guidance on Pre-Submission Facility Correspondence - A Way to Reduce FDA Action Times for Priority ANDAs </title>
      <link>/alerts/fda_issues_draft_guidance_presubmission_facility_correspondence_0717.html</link>
      <guid>/alerts/fda_issues_draft_guidance_presubmission_facility_correspondence_0717.html</guid>
      <pubDate>2017-07-14T15:29:22-04:00</pubDate>
    </item>
    <item>
      <title>Defending the Offensive: SCOTUS Defends Right to Register Offensive Trademarks</title>
      <link>/alerts/scotus_defends_right_register_offensive_trademarks_0617.html</link>
      <guid>/alerts/scotus_defends_right_register_offensive_trademarks_0617.html</guid>
      <pubDate>2017-06-22T16:08:27-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Clarifies Scope of the Patent Exhaustion Doctrine</title>
      <link>/alerts/supreme_court_clarifies_scope_patent_exhaustion_doctrine_0617.html</link>
      <guid>/alerts/supreme_court_clarifies_scope_patent_exhaustion_doctrine_0617.html</guid>
      <pubDate>2017-06-09T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Rules Exporting a Single Component of a Patented Invention Isn&apos;t Infringement Under 35 U.S.C. Section 271(f)(1)</title>
      <link>/alerts/supreme_court_rules_exporting_single_component_patented_invention_not_infringement_0217.html</link>
      <guid>/alerts/supreme_court_rules_exporting_single_component_patented_invention_not_infringement_0217.html</guid>
      <pubDate>2017-02-23T14:49:14-05:00</pubDate>
    </item>
    <item>
      <title>First Circuit Bankruptcy Appellate Panel Latest to Warm Up to Protections for Trademark Licensees in Bankruptcy</title>
      <link>/alerts/first_circuit_bankruptcy_appellate_panel_protections_for_trademark_licensees_in_bankruptcy_1216.html</link>
      <guid>/alerts/first_circuit_bankruptcy_appellate_panel_protections_for_trademark_licensees_in_bankruptcy_1216.html</guid>
      <pubDate>2016-12-12T10:12:05-05:00</pubDate>
    </item>
    <item>
      <title>Chicago Extends Voluntary Disclosure Deadline for Non-Possessory Computer Leases to June 30, 2016</title>
      <link>/alerts/chicago_extends_voluntary_disclosure_deadline_for_nonpossessory_computer_leases_0516.html</link>
      <guid>/alerts/chicago_extends_voluntary_disclosure_deadline_for_nonpossessory_computer_leases_0516.html</guid>
      <pubDate>2016-05-31T16:47:23-04:00</pubDate>
    </item>
    <item>
      <title>Practical Implications for California Companies Under the New Federal Trade Secret Law That Gives Businesses New Means to Protect Their Rights</title>
      <link>/alerts/practical_implications_california_companies_federal_trade_secret_law_0516.html</link>
      <guid>/alerts/practical_implications_california_companies_federal_trade_secret_law_0516.html</guid>
      <pubDate>2016-05-13T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Russia&apos;s Personal Data Localization Law: Expanding Enforcement</title>
      <link>/alerts/russia_personal_data_localization_law_expanding_enforcement_0416.html</link>
      <guid>/alerts/russia_personal_data_localization_law_expanding_enforcement_0416.html</guid>
      <pubDate>2016-04-27T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Russia&apos;s Personal Data Localization Law Goes into Effect</title>
      <link>/alerts/russia_personal_data_localization_law_goes_into_effect_1015.html</link>
      <guid>/alerts/russia_personal_data_localization_law_goes_into_effect_1015.html</guid>
      <pubDate>2015-10-16T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Russia Takes Steps to Implement Import Substitution Plan for Software</title>
      <link>/alerts/russia_steps_implement_import_substitution_plan_for_software_0715.html</link>
      <guid>/alerts/russia_steps_implement_import_substitution_plan_for_software_0715.html</guid>
      <pubDate>2015-07-15T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Russia&apos;s New Personal Data Localization Law Goes into Effect in September 2015</title>
      <link>/alerts/russia_new_personal_data_localization_law_into_effect_september_2015_0615.html</link>
      <guid>/alerts/russia_new_personal_data_localization_law_into_effect_september_2015_0615.html</guid>
      <pubDate>2015-06-15T11:47:28-04:00</pubDate>
    </item>
    <item>
      <title>Winning Streak Continues in ITC Trade Secret Theft Investigations</title>
      <link>/alerts/winning_streak_continues_in_itc_trade_secret_theft_investigations_5580.html</link>
      <guid>/alerts/winning_streak_continues_in_itc_trade_secret_theft_investigations_5580.html</guid>
      <pubDate>2015-05-08T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>California Court of Appeal Ruling Provides Further Guidance for Dealing with Trade Secret Claims Brought in Bad Faith</title>
      <link>/alerts/california_court_of_appeal_further_guidance_dealing_with_trade_secret_claims_bad_faith_5563.html</link>
      <guid>/alerts/california_court_of_appeal_further_guidance_dealing_with_trade_secret_claims_bad_faith_5563.html</guid>
      <pubDate>2015-05-01T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>California Federal Court Dismisses Trade Secret and Other Tort Claims</title>
      <link>/alerts/california_federal_court_dismisses_trade_secret_and_other_tort_claims_5526.html</link>
      <guid>/alerts/california_federal_court_dismisses_trade_secret_and_other_tort_claims_5526.html</guid>
      <pubDate>2015-04-22T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>California Federal Judge Invalidates Spinal Surgery Patents Due to Lack of Objective Boundaries</title>
      <link>/alerts/california_federal_judge_invalidates_spinal_surgery_patents_lack_objective_boundaries_5383.html</link>
      <guid>/alerts/california_federal_judge_invalidates_spinal_surgery_patents_lack_objective_boundaries_5383.html</guid>
      <pubDate>2014-12-01T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Finds Computer Bingo Patents Invalid as Abstract Ideas</title>
      <link>/alerts/federal_circuit_finds_computer_bingo_patents_invalid_as_abstract_ideas_5291.html</link>
      <guid>/alerts/federal_circuit_finds_computer_bingo_patents_invalid_as_abstract_ideas_5291.html</guid>
      <pubDate>2014-08-27T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Requests Comments and Issues Notice of Public Hearing Related to Implementation of GDUFA</title>
      <link>/alerts/fda_requests_comments_and_issues_notice_of_public_hearing_implementation_GDUFA_5289.html</link>
      <guid>/alerts/fda_requests_comments_and_issues_notice_of_public_hearing_implementation_GDUFA_5289.html</guid>
      <pubDate>2014-08-20T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Declines to Issue Rulemaking for Section 505(b)(2) NDA Therapeutic Equivalence Ratings</title>
      <link>/alerts/fda_declines_to_issue_rulemaking_for_nda_therapeutic_equivalence_ratings_5278.html</link>
      <guid>/alerts/fda_declines_to_issue_rulemaking_for_nda_therapeutic_equivalence_ratings_5278.html</guid>
      <pubDate>2014-08-11T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>U.S. Supreme Court Rules on Patent-Eligible Subject Matter</title>
      <link>/alerts/us_supreme_court_rules_on_patent-eligible_subject_matter_5238.html</link>
      <guid>/alerts/us_supreme_court_rules_on_patent-eligible_subject_matter_5238.html</guid>
      <pubDate>2014-06-25T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Inch-by-Inch: FDA&apos;s New Biosimilars Guidance Inches the Industry Closer to Clinical Testing Clarity</title>
      <link>/alerts/fda_new_biosimilars_guidance_inches_industry_closer_clinical_testing_clarity_5204.html</link>
      <guid>/alerts/fda_new_biosimilars_guidance_inches_industry_closer_clinical_testing_clarity_5204.html</guid>
      <pubDate>2014-05-15T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Establishes &quot;Totality of the Circumstances&quot; Framework for Determining Whether Attorney&apos;s Fees Should Be Shifted in Patent Cases</title>
      <link>/alerts/supreme_court_totality_of_the_circumstances_attorney_fees_patent_cases_5199.html</link>
      <guid>/alerts/supreme_court_totality_of_the_circumstances_attorney_fees_patent_cases_5199.html</guid>
      <pubDate>2014-05-06T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Reverses District Court on Claim Construction in Patent Suit Involving Google&apos;s Street View</title>
      <link>/alerts/federal_circuit_reverses_district_court_claim_construction_patent_suit_google_street_view_5159.html</link>
      <guid>/alerts/federal_circuit_reverses_district_court_claim_construction_patent_suit_google_street_view_5159.html</guid>
      <pubDate>2014-03-18T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Sunrise Periods for First Wave of gTLDs Are Now Open</title>
      <link>/alerts/sunrise_periods_first_wave_gTLDs_are_now_open_5084.html</link>
      <guid>/alerts/sunrise_periods_first_wave_gTLDs_are_now_open_5084.html</guid>
      <pubDate>2013-12-09T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>FDA Releases Draft Guidance on Bioequivalence Requirements for ANDA Applicants</title>
      <link>/alerts/FDA_releases_draft_guidance_bioequivalence_requirements_ANDA_applicants_5081.html</link>
      <guid>/alerts/FDA_releases_draft_guidance_bioequivalence_requirements_ANDA_applicants_5081.html</guid>
      <pubDate>2013-12-06T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>FDA Proposed Rule Would Require Generics to Update Label Warnings Even Before Branded Pharmaceuticals Do</title>
      <link>/alerts/fda_proposed_rule_require_genetics_update_label_warnings_before_branded_pharmaceuticals_5063.html</link>
      <guid>/alerts/fda_proposed_rule_require_genetics_update_label_warnings_before_branded_pharmaceuticals_5063.html</guid>
      <pubDate>2013-11-12T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>President Obama Vetoes U.S. International Trade Commission Exclusion Order of Apple Products</title>
      <link>/alerts/president_obama_vetoes_ITC_exclusion_order_apple_products_4975.html</link>
      <guid>/alerts/president_obama_vetoes_ITC_exclusion_order_apple_products_4975.html</guid>
      <pubDate>2013-08-05T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Looks to Short-Circuit Troll Cases</title>
      <link>/alerts/itc_looks_to_short-circuit_troll_cases_4948.html</link>
      <guid>/alerts/itc_looks_to_short-circuit_troll_cases_4948.html</guid>
      <pubDate>2013-07-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Beware of Non-USPTO Solicitations</title>
      <link>/alerts/beware_of_non-USPTO_solicitations_4945.html</link>
      <guid>/alerts/beware_of_non-USPTO_solicitations_4945.html</guid>
      <pubDate>2013-07-08T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Further Defenses to Induced Infringement Following Federal Circuit Decision</title>
      <link>/alerts/further_defenses_to_induced_infringement_following_federal_circuit_decision_4935.html</link>
      <guid>/alerts/further_defenses_to_induced_infringement_following_federal_circuit_decision_4935.html</guid>
      <pubDate>2013-06-28T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>New gTLD Trademark Clearinghouse Launches in Anticipation of New Era of Top-Level Web Domains</title>
      <link>/alerts/gTLD_trademark_clearinghouse_launches_in_anticipation_new_era_top-level_web_domains_4822.html</link>
      <guid>/alerts/gTLD_trademark_clearinghouse_launches_in_anticipation_new_era_top-level_web_domains_4822.html</guid>
      <pubDate>2013-04-03T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Virginia Enacts the First State Law Regulating Interchangeable Biosimilar Products</title>
      <link>/alerts/virginia_enacts_first_state_law_regulating_interchangeable_biosimilar_products_4814.html</link>
      <guid>/alerts/virginia_enacts_first_state_law_regulating_interchangeable_biosimilar_products_4814.html</guid>
      <pubDate>2013-03-28T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Proposes New Limitations on Discovery</title>
      <link>/alerts/ITC_proposes_new_limitations_on_discovery_4619.html</link>
      <guid>/alerts/ITC_proposes_new_limitations_on_discovery_4619.html</guid>
      <pubDate>2012-10-11T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Trade Commission Continues Its Criticism of International Trade Commission</title>
      <link>/alerts/Federal_Trade_Commission_continues_its_criticism_of_International_Trade_Commission_4607.html</link>
      <guid>/alerts/Federal_Trade_Commission_continues_its_criticism_of_International_Trade_Commission_4607.html</guid>
      <pubDate>2012-09-25T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Administrative Law Judge Rules That Ongoing Royalty Precludes Exclusion Order</title>
      <link>/alerts/ITC_administrative_law_judge_rules_that_ongoing_royalty_precludes_exclusion_order_4592.html</link>
      <guid>/alerts/ITC_administrative_law_judge_rules_that_ongoing_royalty_precludes_exclusion_order_4592.html</guid>
      <pubDate>2012-09-11T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Continues to Set a High Bar for Licensing-Based Domestic Industries</title>
      <link>/alerts/ITC_continues_to_set_a_high_bar_for_licensing-based_domestic_industries_4582.html</link>
      <guid>/alerts/ITC_continues_to_set_a_high_bar_for_licensing-based_domestic_industries_4582.html</guid>
      <pubDate>2012-08-30T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Denies Full Relief Based on EPROMs Factors</title>
      <link>/alerts/ITC_denies_full_relief_based_on_EPROMs_factors_4571.html</link>
      <guid>/alerts/ITC_denies_full_relief_based_on_EPROMs_factors_4571.html</guid>
      <pubDate>2012-08-16T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Issues Unusual Stay in Section 337 Case</title>
      <link>/alerts/ITC_issues_unusual_stay_in_section_337_case_4569.html</link>
      <guid>/alerts/ITC_issues_unusual_stay_in_section_337_case_4569.html</guid>
      <pubDate>2012-08-15T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Administrative Law Judge Dismisses Case for Lack of Standing</title>
      <link>/alerts/ITC_administrative_law_judge_dismisses_case_for_lack_of_standing_4563.html</link>
      <guid>/alerts/ITC_administrative_law_judge_dismisses_case_for_lack_of_standing_4563.html</guid>
      <pubDate>2012-08-09T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Chief Administrative Law Judge Finds Privilege Waiver by Third Party</title>
      <link>/alerts/ITC_chief_administrative_law_judge_finds_privilege_waiver_by_third_party_4532.html</link>
      <guid>/alerts/ITC_chief_administrative_law_judge_finds_privilege_waiver_by_third_party_4532.html</guid>
      <pubDate>2012-07-31T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC&apos;s Section 337 Proceedings Pique Congressional Interest</title>
      <link>/alerts/ITC_section_337_proceedings_pique_congressional_interest_4525.html</link>
      <guid>/alerts/ITC_section_337_proceedings_pique_congressional_interest_4525.html</guid>
      <pubDate>2012-07-24T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Proposes Revamping Section 337 Procedures</title>
      <link>/alerts/itc_proposes_revamping_section_337_procedures_4521.html</link>
      <guid>/alerts/itc_proposes_revamping_section_337_procedures_4521.html</guid>
      <pubDate>2012-07-19T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Reverses Itself; Permits ITC to Control Scope of Appeals</title>
      <link>/alerts/federal_circuit_reverses_itself_permits_itc_to_control_scope_of_appeals_4518.html</link>
      <guid>/alerts/federal_circuit_reverses_itself_permits_itc_to_control_scope_of_appeals_4518.html</guid>
      <pubDate>2012-07-16T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Poised to Address Viability of RAND Defense in Section 337 Litigation</title>
      <link>/alerts/itc_poised_to_address_viability_of_rand_defense_in_section_337_litigation_4512.html</link>
      <guid>/alerts/itc_poised_to_address_viability_of_rand_defense_in_section_337_litigation_4512.html</guid>
      <pubDate>2012-07-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Interference with Third-Party Public Interest Participation Circumscribed by ITC</title>
      <link>/alerts/interference_with_third-party_public_interest_participation_circumscribed_by_ITC_4485.html</link>
      <guid>/alerts/interference_with_third-party_public_interest_participation_circumscribed_by_ITC_4485.html</guid>
      <pubDate>2012-06-14T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Ruling May Presage Return of Sanctions Proceedings</title>
      <link>/alerts/ITC_ruling_may_presage_return_of_sanctions_proceedings_4445.html</link>
      <guid>/alerts/ITC_ruling_may_presage_return_of_sanctions_proceedings_4445.html</guid>
      <pubDate>2012-05-02T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>U.S. Supreme Court Restores Generic Pharma&apos;s Ability to Challenge Orange Book Use Code Information</title>
      <link>/alerts/supreme_court_restores_generic_pharma_ability_to_challenge_orange_book_use_code_info_4429.html</link>
      <guid>/alerts/supreme_court_restores_generic_pharma_ability_to_challenge_orange_book_use_code_info_4429.html</guid>
      <pubDate>2012-04-19T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Addresses Infringement of Method-of-Use Patents by Generics in Yasmin Case</title>
      <link>/alerts/federal_circuit_addresses_infringement_method_of_use_patents_by_generics_in_yasmin_case_4428.html</link>
      <guid>/alerts/federal_circuit_addresses_infringement_method_of_use_patents_by_generics_in_yasmin_case_4428.html</guid>
      <pubDate>2012-04-18T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Ruling Requires Heightened Pleading Requirements For Domestic Industry &quot;In The Process Of Being Established&quot;</title>
      <link>/alerts/itc_ruling_requires_heightened_pleading_requirements_for_domestic_industry_4415.html</link>
      <guid>/alerts/itc_ruling_requires_heightened_pleading_requirements_for_domestic_industry_4415.html</guid>
      <pubDate>2012-04-09T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Issues Draft Guidance Documents to Implement the Biologics Price Competition and Innovation Act of 2009</title>
      <link>/alerts/FDA_draft_guidances_implement_biologics_price_competition_innovation_act_4355.html</link>
      <guid>/alerts/FDA_draft_guidances_implement_biologics_price_competition_innovation_act_4355.html</guid>
      <pubDate>2012-02-13T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>FDA Sends Prescription Drug User Fee Act V to Congress for Reauthorization</title>
      <link>/alerts/FDA_sends_prescription_drug_user_fee_act_v_to_congress_for_reauthorization_4339.html</link>
      <guid>/alerts/FDA_sends_prescription_drug_user_fee_act_v_to_congress_for_reauthorization_4339.html</guid>
      <pubDate>2012-01-23T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Triple X: Not Just for the Adult Entertainment Industry</title>
      <link>/alerts/triple_x_not_just_for_the_entertainment_industry_4195.html</link>
      <guid>/alerts/triple_x_not_just_for_the_entertainment_industry_4195.html</guid>
      <pubDate>2011-08-31T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Inception of the Online Red Light District: ICANN to Launch Top-level Domain Extension This Fall</title>
      <link>/alerts/icann_to_launch_top_level_domain_extension_4189.html</link>
      <guid>/alerts/icann_to_launch_top_level_domain_extension_4189.html</guid>
      <pubDate>2011-08-22T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Reverses N.Y. District Court: Claims to &quot;Isolated&quot; DNA Are Eligible for Patent Protection</title>
      <link>/alerts/federal_circuit_finds_claims_to_isolated_dna_eligible_patent_protection_4167.html</link>
      <guid>/alerts/federal_circuit_finds_claims_to_isolated_dna_eligible_patent_protection_4167.html</guid>
      <pubDate>2011-08-02T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA&apos;s Guidelines for Petitions Filed Under Section 505(q) of Food, Drug, and Cosmetic Act</title>
      <link>/alerts/FDA_petition_505(q)_Food_Drug_Cosmetic_Act_ANDA_pharma_4109.html</link>
      <guid>/alerts/FDA_petition_505(q)_Food_Drug_Cosmetic_Act_ANDA_pharma_4109.html</guid>
      <pubDate>2011-06-16T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Affirms Heightened Burden of Proof to Invalidate Patents</title>
      <link>/alerts/Supreme_Court_Microsoft_i4i_USPTO_patent_burden_proof_4102.html</link>
      <guid>/alerts/Supreme_Court_Microsoft_i4i_USPTO_patent_burden_proof_4102.html</guid>
      <pubDate>2011-06-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Rules That Federally Funded Inventions Are Not Automatically Owned by Universities</title>
      <link>/alerts/Supreme_Court_Board_Trustees_Leland_Stanford_University_Roche_Bayh-Dole_invention_patent_4099.html</link>
      <guid>/alerts/Supreme_Court_Board_Trustees_Leland_Stanford_University_Roche_Bayh-Dole_invention_patent_4099.html</guid>
      <pubDate>2011-06-08T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>United Kingdom&apos;s New Laws on Cookies and E-commerce</title>
      <link>/alerts/UK_Vaizey_EU_e-Privacy_Directive_2009-136-EC_cookies_Article_29_4043.html</link>
      <guid>/alerts/UK_Vaizey_EU_e-Privacy_Directive_2009-136-EC_cookies_Article_29_4043.html</guid>
      <pubDate>2011-05-23T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Proposes Pre-marketing User Fees for Biosimilar Product Manufacturers Comparable to Fees for Branded Manufacturers</title>
      <link>/alerts/FDA_biologics_price_competition_innovation_act_user_fee_biosimilar_biological_4073.html</link>
      <guid>/alerts/FDA_biologics_price_competition_innovation_act_user_fee_biosimilar_biological_4073.html</guid>
      <pubDate>2011-05-11T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Federal Government to Provide Its Position on Generic Preemption to the U.S. Supreme Court</title>
      <link>/alerts/federal_government_provide_position_generic_presumption_supreme_court_3751.html</link>
      <guid>/alerts/federal_government_provide_position_generic_presumption_supreme_court_3751.html</guid>
      <pubDate>2010-08-03T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>U.S. Supreme Court Rejects Sole Reliance on Machine-or-Transformation Test for Patent-Eligibility of Processes and Business Methods</title>
      <link>/alerts/Supreme_Court_Patent_Process_Business_Method_3724.html</link>
      <guid>/alerts/Supreme_Court_Patent_Process_Business_Method_3724.html</guid>
      <pubDate>2010-06-29T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Ninth Circuit Holds Application for Copyright Registration Sufficient to Bring Suit in Federal Court</title>
      <link>/alerts/ninth_circuit_application_copyright_sufficient_federal_court_3687.html</link>
      <guid>/alerts/ninth_circuit_application_copyright_sufficient_federal_court_3687.html</guid>
      <pubDate>2010-06-07T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>ITC Rules That Litigation Expenses May Satisfy &quot;Domestic Industry&quot; Requirement for Patents</title>
      <link>/alerts/ITC_Coaxial_Cable_Domestic_Industry_3631.html</link>
      <guid>/alerts/ITC_Coaxial_Cable_Domestic_Industry_3631.html</guid>
      <pubDate>2010-04-20T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>District Court Invalidates Claims to Isolated DNA Molecules and Methods of Their Use; Finds Subject Matter Ineligible for Patent Protection</title>
      <link>/alerts/Myriad_DNA_Patent_3609.html</link>
      <guid>/alerts/Myriad_DNA_Patent_3609.html</guid>
      <pubDate>2010-03-31T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Damage Assessments for False Patent Marking to Be Applied on a Per-Article Basis</title>
      <link>/alerts/false_patent_marking_3524.html</link>
      <guid>/alerts/false_patent_marking_3524.html</guid>
      <pubDate>2010-01-11T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Internet&apos;s Expansion with Internationalized Domain Names May Spur Registration Boom and Cybersquatting</title>
      <link>/alerts/IDN_domain_cybersquatting_3464.html</link>
      <guid>/alerts/IDN_domain_cybersquatting_3464.html</guid>
      <pubDate>2009-11-03T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Pennsylvania Supreme Court Overturns State Trademark Counterfeiting Law</title>
      <link>/alerts/PA_Trademark_Counterfeiting_3440.html</link>
      <guid>/alerts/PA_Trademark_Counterfeiting_3440.html</guid>
      <pubDate>2009-10-09T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Issues Draft Guidance Regarding the Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting</title>
      <link>/alerts/alert3344.html</link>
      <guid>/alerts/alert3344.html</guid>
      <pubDate>2009-07-17T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Facebook&apos;s New Vanity URLs:  Trademark Owners May Need to Protect Their Brands from Infringement</title>
      <link>/alerts/alert3300.html</link>
      <guid>/alerts/alert3300.html</guid>
      <pubDate>2009-06-12T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>SAFETY Act Offers Both Liability Protection and Liability Avoidance for Companies, Directors and Officers, and Preservation of Stockholders&apos; Value</title>
      <link>/alerts/alert3271.html</link>
      <guid>/alerts/alert3271.html</guid>
      <pubDate>2009-05-18T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FDA Issues Draft Guidance Regarding the Submission of Summary Bioequivalence Data for Abbreviated New Drug Applications</title>
      <link>/alerts/alert3223.html</link>
      <guid>/alerts/alert3223.html</guid>
      <pubDate>2009-04-17T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>En Banc Federal Circuit Renders Two Important Patent Decisions; Clarifying Standards for Patentability and Design Patent Infringement</title>
      <link>/alerts/alert3040.html</link>
      <guid>/alerts/alert3040.html</guid>
      <pubDate>2008-11-14T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Supreme Court Expands the Patent Exhaustion Doctrine</title>
      <link>/alerts/alert2871.html</link>
      <guid>/alerts/alert2871.html</guid>
      <pubDate>2008-06-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>New Rules in the N.D. of California Seek to Accomplish More Efficient Patent Trials, with the Help of KSR</title>
      <link>/alerts/alert2777.html</link>
      <guid>/alerts/alert2777.html</guid>
      <pubDate>2008-03-10T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>European Patent Office Rules Changes Are Imminent, Including Official Fees</title>
      <link>/alerts/alert2764.html</link>
      <guid>/alerts/alert2764.html</guid>
      <pubDate>2008-02-29T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Qualcomm Court Sets Baseline for Electronic Discovery Programs for In-House and Retained Counsel</title>
      <link>/alerts/alert2720.html</link>
      <guid>/alerts/alert2720.html</guid>
      <pubDate>2008-01-16T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Third Circuit Decision Clarifies Proper Use of Lapp Factors in Trade Dress Infringement Actions</title>
      <link>/alerts/alert2697.html</link>
      <guid>/alerts/alert2697.html</guid>
      <pubDate>2007-12-31T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Establishes New Standard for Willful Patent Infringement</title>
      <link>/alerts/alert2603.html</link>
      <guid>/alerts/alert2603.html</guid>
      <pubDate>2007-08-24T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>Intangible Holding Companies Under Increased Fire by State Taxing Agencies</title>
      <link>/alerts/alert2594.html</link>
      <guid>/alerts/alert2594.html</guid>
      <pubDate>2007-08-15T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>On Same Day, Supreme Court Renders Two Important Patent Decisions: Clarifying Standard for Obviousness and Extraterritorial Reach of U.S. Patents</title>
      <link>/alerts/alert2497.html</link>
      <guid>/alerts/alert2497.html</guid>
      <pubDate>2007-05-01T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>FTC and DOJ Release Report on Antitrust Enforcement and Intellectual Property Rights</title>
      <link>/alerts/alert2495.html</link>
      <guid>/alerts/alert2495.html</guid>
      <pubDate>2007-04-27T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>In Sweeping Change, Federal Circuit Lowers Threshold for Declaratory Judgment Jurisdiction in Patent Actions</title>
      <link>/alerts/alert2459.html</link>
      <guid>/alerts/alert2459.html</guid>
      <pubDate>2007-03-28T00:00:00-04:00</pubDate>
    </item>
    <item>
      <title>IRS Issues Long-Awaited Initial Guidance on US Taxation of Cross-Licensing of Patents</title>
      <link>/alerts/alert2433.html</link>
      <guid>/alerts/alert2433.html</guid>
      <pubDate>2007-02-16T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Federal Circuit Alert</title>
      <link>/alerts/alert2415.html</link>
      <guid>/alerts/alert2415.html</guid>
      <pubDate>2007-01-29T00:00:00-05:00</pubDate>
    </item>
    <item>
      <title>Patent Licensee in Good Standing Can Challenge Patent under Declaratory Judgment Act</title>
      <link>/alerts/alert2400.html</link>
      <guid>/alerts/alert2400.html</guid>
      <pubDate>2007-01-10T00:00:00-05:00</pubDate>
    </item>
  </channel>
</rss>